EU/3/08/583

Table of contents

About

On 3 December 2008, orphan designation (EU/3/08/583) was granted by the European Commission to Dr. Matthias Luz, Germany, for gadodiamide (liposomal) for the adjunctive treatment of glioma.

Key facts

Active substance
Gadodiamide (liposomal)
Disease / condition
Treatment of glioma
Date of decision
03/12/2008
Outcome
Positive
Orphan decision number
EU/3/08/583

Sponsor's contact details

Dr. Matthias Luz
Brunhildestr. 46
68199 Mannheim
Germany
Tel. +49 6218 1919 39
Fax +49 6218 1919 49
E-mail: matthiasluz@medgenesis.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

How useful was this page?

Add your rating